La pustulose exanthématique aiguë généralisée secondaire à l’hydroxychloroquine : à propos d’un cas
Revue Française d'Allergologie, ISSN: 1877-0320, Vol: 64, Issue: 2, Page: 103781
2024
- 1Citations
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Mentions1
- News Mentions1
- 1
Most Recent News
Study Results from University Hospital Center Provide New Insights into Acute Generalized Exanthematous Pustulosis (Acute Generalized Exanthematous Pustulosis Secondary To Hydroxychloroquine: About a Case)
2024 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- A new study on Skin Diseases and Conditions -
Article Description
La pustulose exanthématique aiguë généralisée (PEAG) est une toxidermie rare mais potentiellement grave. Elle est d’origine médicamenteuse dans la plupart des cas. La PEAG secondaire à l’hydroxychloroquine était rapporté dans une quarantaine de cas dans la littérature. Nous rapportons le cas d’une patiente ayant développé une PEAG suite à la prise d’hydroxychloroquine et ayant bien évolué après arrêt du traitement et mise sous corticoïdes. Acute generalized exanthematous pustulosis (PEAG) is a rare but potentially serious toxidermia. Most cases are drug-induced. PEAG secondary to hydroxychloroquine has been reported in around forty cases in the literature. We report the case of a patient who developed PEAG after taking hydroxychloroquine, which progressed well after discontinuation of treatment and initiation of corticosteroids.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1877032024000010; http://dx.doi.org/10.1016/j.reval.2024.103781; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85184036055&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1877032024000010; https://dx.doi.org/10.1016/j.reval.2024.103781
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know